MATTHEW CLEMENTS: Open Payments
NPI 1588037584 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 11 payments from 5 companies in 2025. Trend: 2023 $269 · 2024 $305 · 2025 $312
Food & beverage: $256Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $109 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 1 | $56 |
| Optinose US, Inc. | 2 | $53 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, NUCALA, Xhance, TEZSPIRE.
Industry payments across SC — which companies pay providers there.
